Prezista label
Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 1 effect
Not studied
Drug 2
Drug 2 effect
Not studied (may increase cyclosporine levels)
Clinical Effects
Potential for increased risk of cyclosporine adverse effects (supratherapeutic immunosuppression, renal toxicity)
Management
If coadministering, initiate lower dose of immunosuppressant, monitor concentrations and toxicity, consult with specialist, and adjust dose as necessary
Import ID
1011
